AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Q32 Bio Inc. Director's Dealing 2018

Mar 27, 2018

34891_dirs_2018-03-27_ed51b872-f485-440d-b976-c3b57b454c11.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2018-03-27

Reporting Person: Rasty Siyamak (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	238707	Direct